Key result
A 49-year-old woman with primary cardiac angiosarcoma treated with a multidisciplinary approach including surgery, radiotherapy, and chemotherapy died 18 months after the initial diagnosis.
Why the study?
Primary cardiac angiosarcoma is extremely rare with poor prognosis, and there are currently no established guidelines for treatment.
Case Report (n=1)
No
Primary cardiac angiosarcoma has a poor prognosis, and while there is no standard treatment, a multidisciplinary approach including surgery, radiation, and chemotherapy is utilized.
Answers are grounded in this paper and cite their sources.
Cardiac angiosarcoma portends poor survival despite multimodal therapy; this case leaves open the need for novel strategies.
INTRODUCTION AND IMPORTANCE: Primary cardiac angiosarcoma is extremely rare, and its prognosis remains poor, with a mean life expectancy of only a few months. Here, we report a case of primary cardiac angiosarcoma. CASE PRESENTATION: A 49-year-old Japanese woman with a month-long history of dyspnea was admitted to our hospital for pericardial effusion. Chest computed tomography and cardiac magnetic resonance imaging showed a mass in the right atrium. The patient underwent surgical resection of the tumor, and the pathological diagnosis was angiosarcoma. The patient received radiotherapy after surgery. Six months following surgery, she underwent chemotherapy following the diagnosis of lung metastasis. The patient died 18 months after the initial diagnosis. CLINICAL DISCUSSION: Cardiac angiosarcoma is rare and difficult to diagnose early because it is associated with few symptoms. Moreover, there are currently no established guidelines for the treatment of this disease because of its rarity and sparse descriptive literature Therefore, multidisciplinary therapies should be considered, including surgery, radiotherapy, and chemotherapy. CONCLUSION: There is no standard treatment for cardiac angiosarcoma, but surgical resection, chemotherapy, radiation therapy, or a combination of these therapies may be useful.
No takes yet. Share an insight, caveat, or question.
Kobayashi et al. (2022) conducted a case report in Primary cardiac angiosarcoma (n=1). Surgical resection, radiotherapy, and chemotherapy was evaluated on Survival. A 49-year-old woman with primary cardiac angiosarcoma treated with a multidisciplinary approach including surgery, radiotherapy, and chemotherapy died 18 months after the initial diagnosis.
Synapse has enriched 10 related papers. Consider them for comparative context: